In contrast to our findings in OAC, high TRPM5-mRNA expression correlated with poor overall survival in patients with melanoma and gastric cancer [50]; high TRPM5-expression did not, however, correlate with poor, overall survival in patients with ovarian, lung, breast, or rectal cancer [50]. The gene discussed is TRPM5; the disease is rectal cancer.